
Elara MD Review
Best for: semaglutide-range and tirzepatide-range GLP-1 plus wellness peptides
Elara MD is a solid telehealth option with balanced features and pricing.
No insurance needed · Vetted by our editors
Elara MD is a weight-loss and wellness telehealth platform offering weekly injectable GLP-1 therapy alongside a peptide menu (NAD+, sermorelin, glutathione). Dose-banded pricing is published on-site: a semaglutide-range plan at $249–$349/month and a tirzepatide-range GLP-1/GIP plus B12 plan at $349–$649/month, with medication included and free shipping when prescribed. Marketed in over 40 states. (Distinct from the separate Elara Health and Wellness.)
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to Elara MD
Wellorithm
Best for: compounded GLP-1 access with oral tablet options across 49 states
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Elara MD at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $249/mo
- FDA status
- No FDA warning letter on record
How we scored Elara MD
Each dimension is scored algorithmically from Elara MD’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
5.5/10At $249/mo, Elara MD runs about 47% above the $169 median for GLP-1 providers.
Effectiveness25%
7.6/10Elara MD offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
6.4/10Online intake and platform experience; 5 platform features disclosed.
Trust & Safety15%
5.5/10Some details we couldn't independently confirm; no FDA warning letters on file (last checked 2026-06-06).
Accessibility10%
5.6/10Elara MD's exact state footprint isn't published — confirm coverage in your state before signing up.
Support10%
5.4/10Elara MD provides standard clinician follow-up; no extended coaching or community program is disclosed.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Elara MD review
Last checked July 2026- Confirmed current pricing across 4 dose/plan tiers
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: low.
What to expect when you sign up with Elara MD
We walked Elara MD’s public signup flow in July 2026 to document the process — the steps, pricing transparency, and what’s required — before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Complete a health questionnaire after clicking Get Started.
- 2A provider reviews your information and issues a personalized treatment plan.
- 3If prescribed, medication ships free within 1-4 days.
- 4You receive a 30-day supply shipped every 30 days, with follow-up visits to track progress.
- Pricing is shown upfront: GLP-1 $249-$349/mo and GLP-1/GIP+B12 $349-$649/mo depending on dose.
- Free shipping in 1-4 days if prescribed.
- A Returns & Refund Policy link exists but specific terms are not detailed on-site.
- Describes itself as an online compounding retailer.
- Support offered via phone and email; no business hours listed.
Elara MD customer support
- Phone
- (888) 688-5470
- hello@elaramd.com
GLP-1 medications Elara MD offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Peptides Elara MD offers
Beyond GLP-1s, Elara MD also offers these peptides — tap any for our evidence-based guide.
Pricing
Prices re-verified
Ready to get started?
Plans and promotions change often — check Elara MD's current pricing and active discounts before you decide.
What we like
- Dose-banded monthly pricing published on-site ($249–$649/mo across tiers)
- Both a semaglutide-range and a tirzepatide-range (GLP-1/GIP) option, plus microdosing
- Medication included in the monthly price with free fast shipping when prescribed
- Broad reach claimed (over 40 states)
Watch-outs
- Molecules not named on-site (only 'Personalized GLP-1') — compounded status is inferred
- No FDA compounded-medication disclaimer published
- No named compounding pharmacy partner — prescriptions are patient-directed
- LegitScript certification, medical director, and full state list not disclosed
- Pricier than several compounded competitors
Elara MD: a transparent price tag wrapped around a thin paper trail
Elara MD is one of the more upfront telehealth platforms when it comes to what you'll actually pay each month, and one of the more guarded about what's actually in the syringe. Its homepage lays out dose-banded pricing in plain sight — something a surprising number of competitors still bury behind a quiz — and bundles the medication and shipping into a single monthly figure. The catch is that almost everything a careful patient would want to confirm before injecting a compounded drug weekly is missing from the site. For shoppers who care more about a published number than a named pharmacy, Elara MD is worth a look. For anyone who wants to know exactly which molecule they're putting in their body and where it was made, the gaps are hard to ignore.
How the dose-banded pricing actually works
Most GLP-1 platforms quote you a single teaser price and let the cost balloon as your dose climbs. Elara MD does the opposite: it publishes the whole ladder. Its semaglutide-range plan starts at $249 a month for a low 0.2 mg weekly dose and rises to the low three hundreds as you titrate up toward 2.2 mg. The tirzepatide-range plan — branded on-site as a GLP-1/GIP shot paired with B12 — runs from the mid three hundreds at 2.0 mg weekly up to roughly the high six hundreds a month at the top 14.0 mg band.
This is genuinely useful. You can map your likely maintenance dose to a real number before you ever enter a card, instead of discovering the true cost three months in. There's no first-month teaser rate here — what you see is the steady-state price — so the figures are honest in both directions. The trade-off is that Elara MD lands on the pricier side of the compounded market. The category median sits near $169 a month, and Elara's entry price is already above that, with the tirzepatide-range tiers climbing well past it.
- Included in every plan: a 30-day supply of medication, shipped every 30 days, with free delivery in one to four days once you're prescribed
- Semaglutide-range plan: $249 to the low three hundreds a month across 0.2–2.2 mg weekly dose bands
- Tirzepatide-range (GLP-1/GIP + B12) plan: mid three hundreds to high six hundreds a month across 2.0–14.0 mg weekly bands
- Microdosing is offered for patients who want to start low and go slow
The medications — and what Elara won't tell you about them
Here's where the picture gets murkier. Elara MD's site never actually names the drugs. The weekly shots are described only as 'Personalized GLP-1' and 'GLP-1/GIP + B12.' Our editors inferred semaglutide and tirzepatide from the dose ranges, the GLP-1/GIP descriptor, and the B12 pairing — but Elara itself never prints those words, never explicitly says the products are compounded, and publishes no FDA disclaimer about compounded medications anywhere on the page. For a weekly injectable, that's a meaningful omission.
Dispensing is patient-directed by design. Elara's own Terms of Use state that while there may be a 'preferred pharmacy,' you have the right to send your prescription to any pharmacy you choose. That sounds like flexibility, and for some patients it is — but it also means there is no named, accredited compounding partner standing behind the product. You can't look up the pharmacy's credentials because Elara doesn't name one.
Beyond GLP-1: the wellness peptide menu
Elara MD isn't a pure weight-loss shop. Alongside the injectables it sells a wellness menu — NAD+ injections, sermorelin (as both injections and troches), and glutathione injections. If you're shopping specifically for GLP-1 weight loss, treat these as a side aisle, not the main event; the peptide market is lightly studied and loosely regulated, and none of it should factor into your decision to trust the core medication program.
Who should choose Elara MD — and who should walk
Elara MD makes sense if transparent, all-in monthly pricing is your top priority and you're comfortable directing your own prescription. The medication-included model with free fast shipping is convenient, the published dose ladder removes a common nasty surprise, and the option to run either a semaglutide-range or tirzepatide-range plan with microdosing gives you room to tailor your approach.
You should skip it if you want verifiable medical oversight. Elara doesn't disclose a medical director or pharmacist-in-charge, doesn't publish a LegitScript certification, and — despite marketing service in 'over 40 states' — never lists which states those are. Its terms are governed by Georgia law, and the operating entity is described only as 'Elara MD and/or our owners and/or affiliates,' with no formal registered company name on file. If you're the kind of patient who reads the fine print, there isn't enough fine print here.
Trust and safety: why we rate confidence LOW
Our review confidence in Elara MD is LOW, and the reasons stack up: the molecules aren't named, compounded status is only inferred, there's no FDA compounded-medication disclaimer, no named pharmacy partner, no disclosed LegitScript ID, no named medical director, and no published state list. To Elara's credit, the site is live and operating, the pricing is real and itemized, and the medication-included-with-free-shipping model is exactly as advertised. But on a weekly injectable, 'the price is honest' can't substitute for 'we know who made the drug and who's supervising your care.' Note too that Elara MD is a distinct company from the similarly named Elara Health and Wellness — different domain, pricing, and service menu — so don't conflate the two when you research.
The bottom line
Elara MD nails the part of GLP-1 telehealth that frustrates patients most — clear, dose-banded pricing with the medication and shipping included and no teaser-rate games. But it leaves out the part that matters most for safety: who is dispensing your drug, what exactly it is, and who is overseeing your care. If you value price clarity above all and you're an informed self-advocate, it's a reasonable option to compare. If you want a named, accredited pharmacy and disclosed medical oversight, several lower-priced compounded competitors give you more for less. Confirm the molecule, the pharmacy, and your state directly with Elara before committing, and weigh it against our scoring methodology before you decide.
For a side-by-side, Wellorithm ($247/month) and Direct Meds ($249/month) are the most comparable options to weigh against Elara MD.
The Bottom Line
Elara MD is a solid telehealth option with balanced features and pricing.
Ready to start with Elara MD?
Starting at $249/month. See current pricing and start your free consultation.
Elara MD might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
- If you want brand-name Ozempic, Wegovy, Mounjaro or Zepbound, consider GobyMeds.
- If the lowest possible monthly price is your top priority, consider Sesame Care (from $59/mo).
- If you want built-in coaching and behavior-change support, consider TMates.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Elara MD review:
Sources & methodology — as of July 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Elara MD's current pricing
Plans start at $249/month. Start your free consultation to check eligibility and today's price.